Dronedarone and Weight increased - a phase IV clinical study of FDA data

Summary:

Weight increased is reported as a side effect among people who take Dronedarone (dronedarone), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Multaq, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Weight increased when taking Dronedarone. It is created by eHealthMe based on reports of 501 people who have side effects when taking Dronedarone from the FDA, and is updated regularly.

What is Dronedarone?

Dronedarone has active ingredients of dronedarone. eHealthMe is studying from 509 Dronedarone users. Check the latest studies of Dronedarone.

What is Weight increased?

Weight increased is found to be associated with 2,885 drugs and 3,951 conditions by eHealthMe. Check the latest studies of Weight increased.

On Jul, 13, 2026

501 people reported to have side effects when taking Dronedarone.
Among them, 12 people (2.4%) have Weight increased.

Could Dronedarone cause Weight increased?

Among these 12 people:

How long have people been on Dronedarone when they have Weight increased? *

What is the gender of people who have Weight increased when taking Dronedarone? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Weight increased when taking Dronedarone? *

What are other drugs people take besides Dronedarone? *

What are other side effects people have besides Weight increased? *

Headache (pain in head): 7 people, 58.33%
Fatigue (feeling of tiredness): 7 people, 58.33%
Nausea (feeling of having an urge to vomit): 7 people, 58.33%
Nausea And Vomiting: 7 people, 58.33%
Dizziness: 7 people, 58.33%
Weakness: 6 people, 50.00%
Oedema Peripheral (superficial swelling): 6 people, 50.00%
Pain In Extremity: 5 people, 41.67%
Intra-Abdominal Haematoma (intra-abdominal localized swelling filled with blood): 5 people, 41.67%
Intra-Abdominal Haemorrhage (intra-abdominal bleeding): 5 people, 41.67%

What are the existing conditions these people have? *

Temporal Arteritis (inflammation and damage to blood vessels that supply the head area): 2 people, 16.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 16.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 8.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 8.33%
Abdominal Distension: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Dronedarone and have Weight increased?

- Check whether Weight increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dronedarone:

Dronedarone (509 reports)

Weight increased treatments and more:

Weight increased (279,369 reports)

Browse all side effects of Dronedarone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight increased:

Weight increased (2,886 drugs)

Browse all the conditions that are associated with Weight increased:

Weight increased (3,951 conditions)

Related publications that referenced our studies

Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on dronedarone (the active ingredients of Dronedarone) and Dronedarone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.